Picture of Biofrontera AG logo

B8FK Biofrontera AG News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Biofrontera Enters Into License And Supply Agreement With Galenica AB

Dec 7 (Reuters) - BIOFRONTERA AG  B8FGn.DE :
    * ENTERS INTO A LICENSE AND SUPPLY AGREEMENT WITH GALENICA
AB FOR
THE MARKETING OF AMELUZ® IN SCANDINAVIA
    * SIGNED AN EXCLUSIVE LICENSE AND SUPPLY AGREEMENT WITH
GALENICA
AB FOR MARKETING OF BOTH AMELUZ® AND BF-RHODOLED® IN SWEDEN,
NORWAY, DENMARK, FINLAND AND ICELAND
    * GALENICA AB RECEIVES EXCLUSIVE DISTRIBUTION RIGHTS FOR
NORDIC
REGIONS, WHEREBY BIOFRONTERA WILL SUPPLY AMELUZ TO GALENICA AT A
TRANSFER PRICE OF 50% OF EXPECTED NET REVENUES

Source text for Eikon:  ID:nPexCSKk4a 
Further company coverage:  B8FGn.DE 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Biofrontera AG

See all news